Bio-Rad Laboratories Operating Margin 2010-2024 | BIO
Bio-Rad Laboratories Operating Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Operating Income | Operating Margin |
2024-06-30 | $2.56B | $0.33B | 12.96% |
2024-03-31 | $2.61B | $0.32B | 12.32% |
2023-12-31 | $2.67B | $0.34B | 12.65% |
2023-09-30 | $2.72B | $0.36B | 13.31% |
2023-06-30 | $2.77B | $0.37B | 13.22% |
2023-03-31 | $2.78B | $0.40B | 14.36% |
2022-12-31 | $2.80B | $0.48B | 17.24% |
2022-09-30 | $2.81B | $0.48B | 17.18% |
2022-06-30 | $2.87B | $0.54B | 18.95% |
2022-03-31 | $2.90B | $0.55B | 18.85% |
2021-12-31 | $2.92B | $0.50B | 17.14% |
2021-09-30 | $2.98B | $0.57B | 19.09% |
2021-06-30 | $2.88B | $0.52B | 18.13% |
2021-03-31 | $2.70B | $0.45B | 16.62% |
2020-12-31 | $2.55B | $0.42B | 16.58% |
2020-09-30 | $2.38B | $0.30B | 12.39% |
2020-06-30 | $2.29B | $0.24B | 10.55% |
2020-03-31 | $2.33B | $0.25B | 10.56% |
2019-12-31 | $2.31B | $0.23B | 9.90% |
2019-09-30 | $2.31B | $-0.06B | -2.47% |
2019-06-30 | $2.29B | $-0.08B | -3.41% |
2019-03-31 | $2.29B | $-0.09B | -3.93% |
2018-12-31 | $2.29B | $-0.10B | -4.50% |
2018-09-30 | $2.29B | $0.18B | 7.85% |
2018-06-30 | $2.28B | $0.18B | 8.02% |
2018-03-31 | $2.21B | $0.14B | 6.19% |
2017-12-31 | $2.16B | $0.12B | 5.51% |
2017-09-30 | $2.11B | $0.04B | 1.99% |
2017-06-30 | $2.09B | $0.03B | 1.49% |
2017-03-31 | $2.10B | $0.06B | 2.67% |
2016-12-31 | $2.07B | $0.06B | 2.71% |
2016-09-30 | $2.07B | $0.14B | 6.58% |
2016-06-30 | $2.03B | $0.14B | 6.95% |
2016-03-31 | $2.02B | $0.16B | 7.83% |
2015-12-31 | $2.02B | $0.17B | 8.22% |
2015-09-30 | $2.05B | $0.16B | 7.72% |
2015-06-30 | $2.11B | $0.16B | 7.50% |
2015-03-31 | $2.14B | $0.16B | 7.67% |
2014-12-31 | $2.18B | $0.15B | 6.90% |
2014-09-30 | $2.18B | $0.15B | 6.93% |
2014-06-30 | $2.15B | $0.15B | 6.82% |
2014-03-31 | $2.14B | $0.15B | 7.19% |
2013-12-31 | $2.13B | $0.17B | 7.92% |
2013-09-30 | $2.10B | $0.19B | 8.94% |
2013-06-30 | $2.10B | $0.23B | 10.72% |
2013-03-31 | $2.08B | $0.25B | 11.76% |
2012-12-31 | $2.07B | $0.26B | 12.76% |
2012-09-30 | $2.05B | $0.29B | 14.13% |
2012-06-30 | $2.06B | $0.30B | 14.40% |
2012-03-31 | $2.08B | $0.29B | 14.07% |
2011-12-31 | $2.07B | $0.31B | 14.71% |
2011-09-30 | $2.06B | $0.29B | 13.95% |
2011-06-30 | $2.01B | $0.29B | 14.31% |
2011-03-31 | $1.96B | $0.29B | 14.70% |
2010-12-31 | $1.93B | $0.28B | 14.73% |
2010-09-30 | $1.89B | $0.26B | 13.87% |
2010-06-30 | $1.88B | $0.25B | 13.53% |
2010-03-31 | $1.84B | $0.24B | 13.17% |
2009-12-31 | $1.78B | $0.23B | 12.89% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.604B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
Stryker (SYK) | United States | $139.112B | 32.51 |
Boston Scientific (BSX) | United States | $123.274B | 37.54 |
Medtronic (MDT) | Ireland | $114.744B | 17.07 |
EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
ResMed (RMD) | United States | $35.702B | 31.43 |
Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
Terumo (TRUMY) | Japan | $28.562B | 40.34 |
Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
Baxter (BAX) | United States | $19.774B | 13.41 |
Insulet (PODD) | United States | $16.665B | 70.11 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
Demant (WILYY) | Denmark | $9.197B | 0.00 |
BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
ICU Medical (ICUI) | United States | $4.428B | 42.25 |
TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
Haemonetics (HAE) | United States | $3.842B | 19.01 |
Neogen (NEOG) | United States | $3.799B | 39.84 |
Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
Envista Holdings (NVST) | United States | $3.324B | 17.73 |
QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
InMode (INMD) | Israel | $1.490B | 9.49 |
Warby Parker (WRBY) | United States | $1.483B | 0.00 |
AtriCure (ATRC) | United States | $1.403B | 0.00 |
Owens & Minor (OMI) | United States | $1.237B | 9.55 |
BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
Evolus (EOLS) | United States | $1.037B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.30 |
Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
Quanterix (QTRX) | United States | $0.594B | 0.00 |
Surmodics (SRDX) | United States | $0.562B | 119.39 |
ZimVie (ZIMV) | United States | $0.468B | 43.49 |
VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
Valneva SE (VALN) | France | $0.419B | 0.00 |
Jin Medical (ZJYL) | China | $0.411B | 0.00 |
Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
Cerus (CERS) | United States | $0.339B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
Biote (BTMD) | United States | $0.331B | 15.27 |
OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
Zynex (ZYXI) | United States | $0.264B | 46.28 |
Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
Omeros (OMER) | United States | $0.234B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
MacroGenics (MGNX) | United States | $0.213B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
High Tide (HITI) | Canada | $0.172B | 71.33 |
Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
Brainsway (BWAY) | Israel | $0.137B | 163.80 |
TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
Veru (VERU) | United States | $0.117B | 0.00 |
Fonar (FONR) | United States | $0.110B | 11.15 |
Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
InterCure (INCR) | Israel | $0.085B | 14.31 |
Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
Safety Shot (SHOT) | United States | $0.076B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
Modular Medical (MODD) | United States | $0.074B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
Exagen (XGN) | United States | $0.050B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
Apyx Medical (APYX) | United States | $0.038B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Sharps Technology (STSS) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 20.48 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |